Legal & General Group’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Legal & General Group's CLBT Position: Q2 2026 in Review
Legal & General Group increased its Cellebrite (CLBT) stake by 32% in Q2 2026, buying an estimated $1.04M and bringing the position to 322,644 shares worth $4.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1613.
Legal & General Group first reported a position in CLBT in Q1 2022 and has held it in 18 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Legal & General Group held 322,644 shares of Cellebrite worth $4.71M as of Q2 2026.
- Legal & General Group bought 78,607 Cellebrite shares in Q2 2026, an estimated $1.04M.
- Cellebrite made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1613 holding.
- Legal & General Group first reported a position in Cellebrite in Q1 2022 and has held it in 18 quarters since.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.